Filing Details
- Accession Number:
- 0001179110-17-015256
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-12 16:57:20
- Reporting Period:
- 2017-12-08
- Accepted Time:
- 2017-12-12 16:57:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651561 | Tabula Rasa Healthcare Inc. | TRHC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
902959 | R Glen Bressner | 205 Webster Street Bethlehem PA 18015 | Yes | No | Yes | No | |
1125761 | J Michael Gausling | 205 Webster Street Bethlehem PA 18015 | No | No | Yes | No | |
1384605 | Originate Growth Fund 1Q Lp | 205 Webster Street Bethlehem PA 18015 | No | No | Yes | No | |
1685942 | R Eric Arnson | 205 Webster Street Bethlehem PA 18015 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-12-08 | 523,805 | $25.85 | 1,390,273 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-11 | 160,375 | $25.85 | 1,229,898 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- Represents shares of the Company's common stock sold by the Reporting Person upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
- This report is filed jointly by Originate Growth Fund #1Q, L.P. ("Originate #1Q"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.